South Africa Plasmid Dna Manufacturing Market Size & Outlook
South Africa plasmid dna manufacturing market, 2018-2030 (US$M)
Related Markets
South Africa plasmid dna manufacturing market highlights
- The South Africa plasmid dna manufacturing market generated a revenue of USD 15.5 million in 2023 and is expected to reach USD 44.0 million by 2030.
- The South Africa market is expected to grow at a CAGR of 16.1% from 2024 to 2030.
- In terms of segment, gmp grade was the largest revenue generating grade in 2023.
- GMP Grade is the most lucrative grade segment registering the fastest growth during the forecast period.
Plasmid dna manufacturing market data book summary
| Market revenue in 2023 | USD 15.5 million |
| Market revenue in 2030 | USD 44.0 million |
| Growth rate | 16.1% (CAGR from 2023 to 2030) |
| Largest segment | Gmp grade |
| Fastest growing segment | GMP Grade |
| Historical data | 2018 - 2022 |
| Base year | 2023 |
| Forecast period | 2024 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | R&D Grade, GMP Grade |
| Key market players worldwide | Charles River Laboratories International Inc, Danaher Corp, Kaneka Corp, Eurofins Scientific SE, Lonza Group Ltd, Akron Biotechnology, Luminous BioSciences, Lonza Group Ltd ADR, Cell & Gene Therapy, Nature Technology, VGXI |
Other key industry trends
- In terms of revenue, South Africa accounted for 0.9% of the global plasmid dna manufacturing market in 2023.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Middle East & Africa, South Africa plasmid dna manufacturing market is projected to lead the regional market in terms of revenue in 2030.
- UAE is the fastest growing regional market in Middle East & Africa and is projected to reach USD 24.3 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Plasmid DNA Manufacturing Market Scope
Plasmid DNA Manufacturing Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
South Africa plasmid dna manufacturing market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to plasmid dna manufacturing market will help companies and investors design strategic landscapes.
Gmp grade was the largest segment with a revenue share of 85.81% in 2023. Horizon Databook has segmented the South Africa plasmid dna manufacturing market based on r&d grade, gmp grade covering the revenue growth of each sub-segment from 2018 to 2030.
South Africa exhibits high potential for the application of gene and cell therapies due to its increasing cancer prevalence. According to the International Agency for Research on Cancer, around 108,168 new cases of cancer were reported in South Africa in 2020.
Such a high cancer burden in the country may result in expansion of therapeutic product portfolios and propel the demand for plasmid DNA & viral vectors for development of novel gene therapies.
Moreover, several strategic initiatives undertaken by global firms to develop a skill set to boost in-house production of viral vector vaccines in the country are expected to drive the market.
Reasons to subscribe to South Africa plasmid dna manufacturing market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of South Africa plasmid dna manufacturing market databook
-
Our clientele includes a mix of plasmid dna manufacturing market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the South Africa plasmid dna manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into South Africa plasmid dna manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
South Africa plasmid dna manufacturing market size, by grade, 2018-2030 (US$M)
South Africa Plasmid DNA Manufacturing Market Outlook Share, 2023 & 2030 (US$M)
Related regional statistics
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
